Lifeward Ltd. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability

Reuters
05/22
<a href="https://laohu8.com/S/LFWD">Lifeward Ltd</a>. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability

Lifeward Ltd., formerly known as ReWalk Robotics, has unveiled its latest investor presentation, highlighting its innovative technologies aimed at transforming the lives of individuals with physical limitations or disabilities. The company has made significant strides with its ReWalk Personal Exoskeleton, which has received both FDA and CE approvals, and the AlterG Anti-Gravity Systems, utilizing NASA-derived Differential Air Pressure technology. Lifeward Ltd. is also expanding its market presence, particularly in the U.S. and Germany, with Medicare coverage in place since April 2024. The company is focusing on securing private insurance coverage to further grow its addressable market. Lifeward Ltd. is on a path to profitability, expecting to reduce operating losses in 2025 and achieve profitability by 2026. The full presentation can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10